Respiratory Trials·org

Sepsis & septic shock · What to resuscitate towards

ANDROMEDA-SHOCK-2 randomised trial

Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock

ANDROMEDA-SHOCK-2 trial design and results
Design Multicentre randomised clinical trial with a hierarchical composite endpoint
Treatment Personalised haemodynamic resuscitation targeting capillary refill time
Control Usual care
Population 1467 patients analysed with early septic shock, mean age 66, 43.3% female
Follow-up 28 days
Primary endpoint Hierarchical composite analysed by win ratio
Result There were 131,131 wins (48.9%) in the capillary refill time group versus 112,787 (42.1%) in the usual care group for the hierarchical composite.
Secondary endpoints Mortality, organ dysfunction, resuscitation intensity

Among patients with early septic shock, a personalized hemodynamic resuscitation protocol targeting capillary refill time was superior to usual care for the primary composite outcome, primarily due to a lower duration of vital support.

The trial authors, in the published abstract

How it has aged

After two decades of failed protocols (Rivers EGDT and its three replications), a target that requires nothing more than a finger and a stopwatch outperforms usual care. Win-ratio composites are hard to interpret clinically, so the practical size of the benefit is less clear than its direction.

Publications

Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial

Hernandez G, Ospina-Tascón GA, Kattan E, et al. Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. JAMA 2025 Dec 9;334(22):1988-1999.

  • 48.9% wins versus 42.1% on the hierarchical composite
  • Target requires no invasive monitoring